EYEN: Eyenovia, Inc. Company Cash Volume

Official company branding of eyenovia.com (EYEN)

Eyenovia, Inc. is scaling its ophthalmological therapy through partnerships with medical centers, integrating the Optejet system into third-party formulas. The company's cash position illustrates the issuer's financial stability, while the 0.00 mark reflects the latest data. Geopolitical instability is hindering international trials and reagent procurement; however, the commercial launch of micro-dosed spraying is expanding the clinic network, offering patients an alternative to conventional drops.

EYEN - Eyenovia Company Cash Volume over the range 07/04/2022 - 07/03/2025

Analytical breakdowns and data insights for company eyenovia.com (EYEN)

- current price and projected stock value:
Summary company analytics:Eyenovia, Inc.
Brand item of Eyenovia, Inc.

This metric captures the absolute volume of liquid assets, directly reflecting the business's ability to fund operating activities without external borrowing. This indicator allows for a comparison of real cash reserves against market capitalization to assess the company's intrinsic value. For Eyenovia, Inc. (EYEN), maintaining capital is critical during clinical trials, as the demand for glaucoma treatment remains independent of economic conditions. By analyzing cash and cash equivalents, an investor determines the business's margin of safety. The trend of this indicator demonstrates the burn rate of funds allocated to the development of innovative drug delivery systems.